These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9762672)

  • 1. Monitoring multiple sclerosis course and activity with TNF-alpha.
    Chofflon M; Fellay B
    Mult Scler; 1998 Jun; 4(3):188-92. PubMed ID: 9762672
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of TNF-alpha synthesis with thalidomide for prevention of acute exacerbations and altering the natural history of multiple sclerosis.
    Sastry PS
    Med Hypotheses; 1999 Jul; 53(1):76-7. PubMed ID: 10499831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between in vitro cytokine production and clinical evolution of multiple sclerosis patients.
    Chofflon M; Juillard C; Gauthier G; Grau GE
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):107-12. PubMed ID: 1710376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis.
    Chofflon M; Juillard C; Juillard P; Gauthier G; Grau GE
    Eur Cytokine Netw; 1992; 3(6):523-31. PubMed ID: 1296800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
    Sharief MK; Hentges R
    N Engl J Med; 1991 Aug; 325(7):467-72. PubMed ID: 1852181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of evoked potential examination for monitoring in multiple sclerosis].
    Nagaura T; Sumi S
    No To Hattatsu; 1993 Jan; 25(1):90-2. PubMed ID: 8416703
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis.
    Chofflon M; Roth S; Juillard C; Paunier AM; Juillard P; Degroote D; Grau GE
    Eur Cytokine Netw; 1997 Sep; 8(3):253-7. PubMed ID: 9346357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytokine production by peripheral blood monocytes/macrophages in the patients with multiple sclerosis and its suppression by methylprednisolone].
    Imamura K; Hayashi F; Suzumura A
    Rinsho Shinkeigaku; 1992 Mar; 32(3):276-80. PubMed ID: 1628450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis?
    Hohlfeld R
    Mult Scler; 1996 Jul; 1(6):376-8. PubMed ID: 9345421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Production of cytokines from blood donor leukocytes].
    Shcheglovitova ON; Parshina OV; Guseva TS; Maksianina EV; Ershov FI
    Vopr Virusol; 2001; 46(6):36-8. PubMed ID: 11785386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by a rat corneal epithelial cell line.
    Józwiak J; Skopiński P; Malejczyk J
    Int J Tissue React; 2000; 22(4):105-10. PubMed ID: 11199339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production of tumor necrosis factor-alpha and interleukin-1 beta in patients with pulmonary tuberculosis in relation to the course of a process and immunological features].
    Knoring BE; Simbirtsev AS; Sakharova II; Kotov AI
    Probl Tuberk; 1996; (5):35-9. PubMed ID: 8984489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS.
    Sippy BD; Hofman FM; Wallach D; Hinton DR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):511-21. PubMed ID: 8548330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body fluid markers to monitor multiple sclerosis: the assays and the challenges.
    Laman JD; Thompson EJ; Kappos L
    Mult Scler; 1998 Jun; 4(3):266-9. PubMed ID: 9762687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.
    Buttinelli C; Toma L; Falcone MM; Salvetti M; Ristori G; Barnaba V; Fieschi C
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):79-83. PubMed ID: 1345744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytokine profiles as indicators of relapse activity and clinical course in multiple sclerosis.
    Schluep M; van Melle G; Henry H; Städler C; Roth-Wicky B; Magistretti PJ
    Mult Scler; 1998 Jun; 4(3):198-202. PubMed ID: 9762674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.
    Robinson P; Okhuysen PC; Chappell CL; Lewis DE; Shahab I; Janecki A; White AC
    Infect Immun; 2001 Feb; 69(2):1172-4. PubMed ID: 11160015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic stabilometry as a monitoring of movement and coordination disorders in the rehabilitation of patients with multiple sclerosis].
    Popova NF; Shagaev AS; Demina TL; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):35-9. PubMed ID: 19156084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth potentiating activity of endogenous production of interleukin-1 and tumor necrosis factor alpha in blast cells of acute myeloblastic leukemia.
    Murohashi I; Tohda S; Imai Y; Hirai Y; Nara N
    Exp Hematol; 1993 Jul; 21(7):846-51. PubMed ID: 8319777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cytotoxicity and production of interleukin-1 and tumor necrosis factor from blood monocytes of cervical carcinoma patients.
    Nadkarni JJ; De AK; Jhaver KJ; Kamat MR
    Neoplasma; 1994; 41(2):123-8. PubMed ID: 8208316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.